Vascular Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF) in Patients With Acute Coronary Syndrome (ACS)

This study has been completed.

Sponsor:

Information provided by:

Institute of Cardiology, Warsaw, Poland

ClinicalTrials.gov Identifier:

NCT00844987

First received: February 13, 2009

Last updated: May 26, 2010

Last verified: May 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2009
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

No publications provided by Institute of Cardiology, Warsaw, Poland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Konopka A, Janas J, Piotrowski W, Stępińska J. Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine. 2013 Feb;61(2):664-9. doi: 10.1016/j.cyto.2012.12.001. Epub 2013 Jan 10.

Konopka A, Janas J, Piotrowski W, Stepi?ska J. Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome. Growth Factors. 2010 Apr;28(2):75-81.

To Top